In Japan, clinical trials for drugs require approval from the Pharmaceuticals and Medical Devices Agency (PMDA), adherence to Good Clinical Practice (GCP) guidelines, ethical review board approval, informed consent from participants, and compliance with the Clinical Trials Act. Trials must also be registered in the Japan Registry of Clinical Trials (jRCT).
